Professor Zheng Yongqi has won the American Leukemia Research Scholar Award, Cornelius Rhodes American Cancer Research Center Research Award, American National Cancer Center Outstanding Contribution Award, Brown University Outstanding Alumni Award and American Pharmacology and Experimental Therapeutics Association Award. Professor Zheng Yongqi is currently a chair professor in the Department of Pharmacology, Yale University. He and the Department of Pharmacy of Yale University where he works are one of the most important teams in the research of nucleic acid derivatives in the world. He is also an academician of Academia Sinica in Taiwan. So far, Professor Zheng has invented three kinds of drugs for treating viral diseases internationally, published more than 400 academic papers, and established two API companies based on his own scientific research results, one of which has been listed.

Professor Zheng Yongqi initiated the establishment of the "Globalization Alliance of Traditional Chinese Medicine" and served as its chairman, aiming at bringing together the top research institutions in the world to make joint efforts to make traditional Chinese medicine lose its traditional and regional role, become a drug that can be recognized by western countries, and pass the certification of FDA in the United States to promote Chinese medicine to the world. Become a part of the international medical system, further promote the health of all mankind, and become the basis for the future development of mainstream medicine in the world. China, the United States, Britain, Canada, Australia, Japan, South Korea, Malaysia and Singapore have joined the alliance, and 76 academic institutions have participated to jointly promote and promote the global research and development of traditional Chinese medicine.

Professor Zheng is currently an advisor to the Chairman of the Alliance for Globalization of Traditional Chinese Medicine, an academician of the Taiwan Academia Sinica, an academician of the Connecticut Academy of Sciences, a professor of pharmacology at Yale University, an honorary professor of Peking University and Zhejiang University, and the chief advisor of traditional Chinese medicine at the Shanghai Institute of Life, China Academy of Sciences. From June 2008 to February 2008, he was employed as an honorary professor of Xiamen University to guide the research work of the Institute of Biomedical Sciences.